ClearNote Health | Early Cancer Detection

Abstracts and Poster Presentations

ClearNote Health is driving innovation in non-invasive cancer detection, with patient needs at the core of everything we pursue. Based on more than 50,000 assays with samples collected across over 150 sites, we have produced multiple abstracts and delivered countless poster presentations covering detection data from several cancer types, including pancreatic and ovarian.

Cell-free DNA 5-hydroxymethylcytosine Profiling for the Assessment of Colorectal Cancer Biology and Treatment Response in Blood.

Meeting Abstract: 2025 ASCO Annual Meeting
Publication: Journal of Clinical Oncology Volume 43, Number 16

5hmC-seq of mCRPC cfDNA identifies loss of AR signaling in NEPC and DNPC

Meeting Abstract: AACR 2025, Chicago, USA Publication: Cancer Research (2025) 85 (8_Supplement_1): 1985.

A tumor-naïve method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell–free DNA

Meeting Abstract: AACR 2025, Chicago, USA Publication: Cancer Research (2025) 85 (8_Supplement_1): 3681

Cell-Free DNA Epigenomic-Based Test Is Predicted to Be Cost-Effective to Manage New-Onset Type 2 Diabetes Patients for Risk of Pancreatic Cancer

November 2024, ISPOR Europe 2024, Barcelona, Spain
Value in Health, Volume 27, Issue 12, S2 (December 2024)

Detection of High-Risk Pancreatic Cysts Using Avantect™ Blood-Based Test

Digestive Disease Week, May, 2024

SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.

American Pancreatic Association, December 2023

Epigenomics-based Tests for Early Cancer Detection

Learn About Our Tests

Name	Provider	Purpose	Expiration
_cf_bm	Clearnotehealth.com	This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.	1 day
AWSALB	Clearnotehealth.com	Registers which server-cluster is serving the visitor. This is used in context with load balancing, in order to optimize user experience.	7 days
AWSALBCORS	Clearnotehealth.com	Registers which server-cluster is serving the visitor. This is used in context with load balancing, in order to optimize user experience.	7 days
AWSELB	App.jazz.co	Used to distribute traffic to the website on several servers in order to optimise response times.	Session
AWSELBCORS	App.jazz.co	Registers which server-cluster is serving the visitor. This is used in context with load balancing, in order to optimize user experience.	Session
rc::a	Google.com	This cookie is used to distinguish between humans and bots. This is beneficial for the website, in order to make valid reports on the use of their website.	Persistent
rC::C	Google.com	This cookie is used to distinguish between humans and bots.	Session
SF PHPSESSID	App.jazz.co	Necessary for third-party recruitment app.	Session

Name	Provider	Purpose	Expiration
ads/ga-audiences x2	Www.googletagmanager.com	Used to detect whether the user intends to leave the page via cursor. This allows the website to trigger certain pop-ups to keep the user on the website or convert them to customer.	Session
external referrer _url	app.jazz.co	Registers how the user has reached the website to enable pay-out of referral commission fees to partners.	1 day
internal navigation count	app.jazz.co	Unclassified	1 day
ubwc	static.userback.io	Unclassified	Persistent
_ga	Www.googletagmanager.com	Registers a unique ID that is used to generate statistical data on how the visitor uses the website.	2 years
_ga_#	Www.googletagmanager.com	Used by Google Analytics to collect data on the number of times a user has visited the website as well as dates for the first and most recent visit.	2 years
_gat	www.google-analytics.com	Used by Google Analytics to throttle request rate	1 day
gid	www.google-analytics.com	Registers a unique ID that is used to 1 day generate statistical data on how the visitor uses the website.	1 day
collect	Www.googletagmanager.com	Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.	Session
td	Www.googletagmanager.com	Registers statistical data on users' behaviour on the website. Used for internal analytics by the website operator.	Session
userback session apP	Clearnotehealth.com	Registers statistical data on users' behaviour on the website. Used for internal analytics by the website operator.	3 months
LinkedIn Insight Tag: _li_uuid _linkedin_uuid	LinkedIn	Registers how the user has reached the website and what pages they visit related to LinkedIn analytics and advertising.	2 years

Abstracts and Poster Presentations

Cell-free DNA 5-hydroxymethylcytosine Profiling for the Assessment of Colorectal Cancer Biology and Treatment Response in Blood.

5hmC-seq of mCRPC cfDNA identifies loss of AR signaling in NEPC and DNPC

A tumor-naïve method for estimating tumor fraction using 5-hydroxymethylation cytosine in cell–free DNA

Cell-Free DNA Epigenomic-Based Test Is Predicted to Be Cost-Effective to Manage New-Onset Type 2 Diabetes Patients for Risk of Pancreatic Cancer

Detection of High-Risk Pancreatic Cysts Using Avantect™ Blood-Based Test

SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.

Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting.

Automation of an Early Detection Pancreatic Cancer Test Using 5-Hydroxymethylation Profiles.

Evaluation of the Avantect Pancreatic Cancer Test for Identifying High-Risk Pancreatic Cysts.

Early detection of pancreatic cancer using 5-hydroxymethylation profiles in plasma-derived cell-free DNA.

Epigenomics-based Tests for Early Cancer Detection